MENU
MAZE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Maze Therapeutics (MAZE) Ownership - Who owns Maze Therapeutics?

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.42B
P/E Ratio
191.34
Total Cash
383.94M
Projected Growth
N/A
Total Debt
24.18M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.94
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
View a ticker or compare two or three
MAZE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details